Walleye Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Walleye Trading’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,000	Closed	-$1.69M	–	6118
2021 Q2	$1.69M	Buy	50,000 +43,000	+614%	+$1.1M	0.01%	1635
2021 Q1	$164K	Buy	7,000 +800	+13%	+$24.2K	﹤0.01%	3798
2020 Q4	$179K	Buy	+6,200	New	+$156K	﹤0.01%	3600
2020 Q3	–	Sell	-3,000	Closed	-$90K	–	4850
2020 Q2	$90K	Buy	+3,000	New	+$108K	﹤0.01%	3569

Walleye Trading's CNST Position: Q3 2021 in Review

Walleye Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,801 shares — an estimated $669K sold.

Walleye Trading first reported a position in CNST in Q1 2020 and held it in 3 quarters. The position peaked at $669K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Walleye Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Walleye Trading sold 19,801 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $669K.
Walleye Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
Walleye Trading's Constellation Pharmaceuticals, Inc. position peaked at $669K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.